Release date: 2024-07-10 11:32:53 Recommended: 119

Iclusig is used to treat certain specific stages of leukemia, but is not suitable and not recommended for the treatment of newly diagnosed chronic myeloid leukemia patients. It belongs to tyrosine kinase inhibitors, which inhibit abnormal tyrosine kinase activity in leukemia cells, blocking the proliferation and survival of leukemia cells. Iclusig is suitable for the treatment of chronic myeloid leukemia and Ph+acute lymphoblastic leukemia, especially for patients who are tolerant or intolerant to other therapeutic drugs.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:400Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:397Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:459Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:325Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:533Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended:325Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:507Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:399Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:159Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:153Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended:171Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended:153Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended:187Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended:167Release date: 2025-12-01